163
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Development and validation of LC/MS method for the determination of meclizine enantiomers in pharmaceutical formulations

, , ORCID Icon, &
Pages 361-366 | Received 23 Jul 2020, Accepted 06 Dec 2020, Published online: 19 Feb 2021

References

  • FDA'S. Policy Statement Dev. New Stereo Drugs Chirality. 1992;4:338–340.
  • Fekete S, Oláh E, Fekete J. Fast liquid chromatography: the domination of core-shell and very fine particles. J Chromatogr A. 2012;1228:57–71.
  • Gowramma B, Meyyanathan SN. Development and validation of LC-MS/MS method for the estimation of zaltoprofen enantiomers in pharmaceutical formulation. Int J Pharma Bio Sci. 2013;4(1):883–889.
  • Biba M, Regalado EL, Wu N, et al. Effect of particle size on the speed and resolution of chiral separations using supercritical fluid chromatography. J Chromatogr A. 2014;1363:250–256.
  • Patel DC, Breitbach ZS, Wahab MF, et al. Gone in seconds: praxis, performance, and peculiarities of ultrafast chiral liquid chromatography with superficially porous particles. Anal Chem. 2015;87(18):9137–9148.
  • Gowramma B, Senthil Kumar R, Kalirajan R, et al. enantiomeric separation of meclizine hydrochloride in pharmaceutical dosage Form by HPLC method. CDRR. 2020;12(1):63–71.
  • Hardmann JG, Limbird LE, Molinoff PB, editors. et al. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 1996.
  • Ashwini SJ, Narenderan ST, Meyyanathan SN, et al. A validated chiral HPLC method for the enantiomeric separation of mefloquine. Res J Pharm Technol. 2019;12(5):2304–2308.
  • Eto S, Noda H, Noda A. High-performance liquid chromatographic method for direct separation of 5-(p-hydroxyphenyl)-5-phenylhydantoin enantiomers using a chiral tris(4-methylbenzoate) column. J Chromatogr. 1991;568(1):157–163.
  • Ashwini SJ, Narenderan ST, Meyyanathan SN, et al. Enantiomeric separation of midodrine HCl in bulk and pharmaceutical dosage form by chiral HPLC. Int. J Pharm Sci. 2019;10(2):1–4.
  • Gowramma B, Meyyanathan SN, Babu B, et al. A new validated stability-indicating direct high-performance liquid chromatography method for the determination of rosiglitazone enantiomers in the presence of its degradation products. Asian J Pharm Clin Res. 2019;12(3):64–67.
  • Senthil Kumar R, Meyyanathan SN, Gowramma B. Stability indicating chiral HPLC method for the estimation of pioglitazone enantiomers in pharmaceutical formulation. Asian J Pharm Clin Res. 2015; 8(5):63–66.
  • Jacek B, Hassan Y, Aboul E, et al. What’s new in chromatographic enantio separations. Curr Anal Chem. 2005;1:59–77.
  • Senthil Kumar R, Meyyanathan SN, Gowramma B. A new validated chiral RP HPLC method for the determination of stability of mebeverine enantiomers in the presence of its degradation products. Int. J. Pharm. Pharm. Sci. 2015; 7(5):112–116.
  • Senthil Kumar R, Meyyanathan SN, Gowramma B. Chiral RP HPLC method for enantiomeric separation of mebeverine hydrochloride in formulations. Indo Am J Pharm. 2015; 5(8):2756–2764.
  • Gowramma B, Meyyanathan SN, Gomathy S, et al. Stability indicating chiral HPLC method for the estimation of zaltoprofen enantiomers in pharmaceutical formulation. Int J Pharm Pharm Sci. 2014; 6(2):584–587.
  • Krishnaveni N, Gowramma B, Madhuri L, et al. Development and validation of a stability indication RP HPLC method for the determination of valgfanciclovir HCl (RS). J Pharm Anal. 2014; 3(1):19–26.
  • Gowramma B, Meyyanathan SN, Krisnaveni N, et al. Chiral HPLC method for determination o f S and R zaltoprofen in pharmaceutical formulation. Contemp Investig Observ Pharm. 2012;1(2):103–109.
  • Gowramma B, Babu B, Meyyanathan SN, et al. Chiral HPLC method for the enantioselective analysis of rosiglitazone maleate in formulations. J Pharm Res. 2012;5(1):79–81.
  • Gowramma B, Babu B, Meyyanathan SN, et al. New chiral normal phase HPLC method for determination of pioglitazone enantiomers on its marketed formulation. J Pharm Res. 2012;5(1):72–74.
  • Gowramma B, Meyyanathan SN, Babu B, et al. Development and validation of LC-MS/MS Method for the estimation of pioglitazone enantiomers in pharmaceutical formulation. Int J Pharm Biol Sci. 2013;4(2):86–91.
  • Gowramma B, Meyyanathan SN, Babu B, et al. Development and validation of LC-MS/MS method for the estimation of rosiglitazone enantiomers in pharmaceutical formulation. Int Res J Pharm. 2012;3(9):123–126.
  • Nie Y, Liu X, Yang X, et al. Review: recent application of chiral liquid chromatography-tandem mass spectrometric methods for enantiomeric pharmaceutical and biomedical determinations. J Chromatogr Sci. 2013;51(8):753–763.
  • Erny GL, Cifuentes A. Liquid separation techniques coupled with mass spectrometry for chiral analysis of pharmaceuticals compounds and their metabolites in biological fluids. J Pharm Biomed Anal. 2006;40(3):509–515.
  • Chen J, Korfmacher WA, Hsieh Y. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations. J Chromatogr B. 2005;820(1):1–8.
  • Barhate CL, Breitbach ZS, Pinto EC, et al. Ultrafast separation of fluorinated and desfluorinated pharmaceuticals using highly efficient and selective chiral selectors bonded to superficially porous particles. J Chromatogr A. 2015;1426:241–247.
  • Zawatzky K, Biba M, Regalado EL, et al. MISER chiral supercritical fluid chromatography for high throughput analysis of enantiopurity. J Chromatogr A. 2016;1429:374–379.
  • Hassan Y, Aboul E, Rafiqul IM. Enantiomeric separation of ketamine hydrochloride in pharmaceutical formulation and human serum by chiral liquid chromatography. J Liq Chromatogr. 1992;15(18):3285–3293.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.